← Back to Patent Explorer
US4451453A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for treating contact dermatitis

Assignee: Dow Chemical Co
•
Filing: 1982-04-13
•
Granted: 1984-05-29
•
Expires: 2002-04-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Contact dermatitis caused by exposure of the skin to the allergen present in plants of the genus Rhus, is treated and controlled by topical application of an effective amount of an allergen-imbibing, allergen-retaining polymer or a pharmaceutically-acceptable composition containing such polymer.

Inventors

  • 👤 George E. Lay
  • 👤 Daniel H. Haigh

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 08:08
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/74; A61K31/745; A61K31/765; A61K31/78

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 77 words
A method of controlling and treating dermatitis in humans caused by exposure of the skin to a plant of the genus Rhus which comprises the topical application of an effective amount of an allergen-imbibing, allergen-retaining polymer wherein said polymer is a crosslinked copolymer of isobornyl acrylate, isobornyl methacrylate, styrene, or alkylstyrene and at least one ester of a C 8 to C 20 fatty alcohol with acrylic or methacrylic acid, crosslinked with a polyethylenically unsaturated crosslinking agent.
Claim 2
Independent Claim 77 words
A method of controlling and treating dermatitis in humans caused by exposure of the skin to a plant of the genus Rhus which comprises the topical application of an effective amount of an allergen-imbibing, allergen-retaining polymer wherein said polymer is a crosslinked copolymer of isobornyl acrylate, isobornyl methacrylate, styrene, or alkylstyrene and at least one ester of a C 8 to C 20 fatty alcohol with acrylic or methacrylic acid, crosslinked with a polyethylenically unsaturated crosslinking agent.
Claim 3
Dependent Claim 68 words
The method of claim 1 wherein the polymer is a copolymer of from about 60 to about 90 percent by weight of a tertiary-alkylstyrene and at least one ester of a C 8 to C 20 fatty alcohol with acrylic or methacrylic acid, crosslinked with from about 0.001 to about 0.1 percent (based on the total weight of said tertiary-alkylstyrene and ester) of a polyethylenically unsaturated crosslinking agent.
Claim 4
Dependent Claim 10 words
The method of claim 1 wherein the tertiary-alkylstyrene is tertiary-butylstyrene.
Claim 5
Dependent Claim 11 words
The method of claim 3 wherein the crosslinking agent is divinylbenzene.
Claim 6
Dependent Claim 21 words
The method of claim 3 wherein the tertiary-alkylstyrene is tertiary-butylstyrene and the ester is a C 8 to C 20 methacrylate.
Claim 7
Dependent Claim 15 words
The method of claim 5 wherein the polymer is a copolymer of tertiary-butylstyrene and laurylmethacrylate.
Claim 8
Independent Claim 27 words
The method of claims 1, 2 or 6 wherein the polymer is applied in combination with a pharmaceutically-acceptable carrier in a polymeric composition suitable for topical application.

References Cited (Backward Citations)

US3849576A Cited
US3976781A Cited
US3322695A Cited
US3615972A Cited
US3520806A Cited
US4039489A Cited
US3750688A Cited
US3953406A Cited
US4071670A Cited
US4112067A Cited
US4186191A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-05-29 1987-11-28 1988-05-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-05-29 1991-11-28 1992-05-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-05-29 1995-11-28 1996-05-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag